Cd38 Recombinant: Top Quality for Research and Clinical Applications

Looking for a reliable source of Cd38 Recombinant? Look no further than Alpha Lifetech Incorporation. Our Cd38 Recombinant product offers high purity and quality, ensuring reliable results for your research needs, Our Cd38 Recombinant is produced using cutting-edge technology and strict quality control measures to guarantee its effectiveness and consistency. It is suitable for a wide range of applications, including cell biology, immunology, and cancer research, At Alpha Lifetech Incorporation, we are committed to providing top-notch products to support the advancement of scientific research. Our Cd38 Recombinant is no exception, as it is backed by our team of experienced scientists and rigorous testing procedures, Trust Alpha Lifetech Incorporation for all your Cd38 Recombinant needs. Our dedication to excellence and customer satisfaction sets us apart as a leading provider in the life sciences industry. With our Cd38 Recombinant, you can be confident in the integrity of your research and the reliability of your results. Contact us today to learn more about our Cd38 Recombinant and how it can benefit your work

Hot Selling Product

ADT1005-Abciximab Biosimilar: (ITGA2B_ITGB3)- Research Grade

ALP64511-Recombinant Cynomolgus Monkey TNFRSF17/BCMA Protein, His Tag

ALP64536-Recombinant Cynomolgus Monkey TNFSF18/GITRL Protein, His Tag

ALP64559-Recombinant Human CD47/MER6 Protein, mFc Tag

ADT1394-Mezagitamab Biosimilar-Anti-CD38 mAb-Research Grade

ADT1411-MOR202 Biosimilar-Anti-CD38 mAb-Research Grade

Making Smart Choices Cd38 Recombinant Guarantees Peak Performance Your End-to-End Solution

At Alpha Lifetech Inc., we understand the importance of making smart choices in research and development. Our commitment to excellence is embodied in our latest offering: the CD38 Recombinant Protein. This high-quality product is engineered to support peak performance in your projects, providing an end-to-end solution for scientists and researchers globally. With nearly 10,000 different high-quality spot membrane protein reagents, cytokines, and drug target antibodies at your disposal, you can be confident that our CD38 Recombinant will meet rigorous standards of reliability and efficacy. Founded by a talented team of scientists with extensive experience in membrane protein production and monoclonal development, Alpha Lifetech Inc. stands at the forefront of biotechnology innovation. The CD38 Recombinant is not just a product; it's a strategic choice that can enhance your research efficiency and accuracy. By integrating cutting-edge technology and expertise, we ensure that our offerings empower you to forge ahead in your scientific inquiries while minimizing risks and maximizing outcomes. In an increasingly competitive landscape, partnering with Alpha Lifetech Inc. means equipping yourself with the tools necessary for success. Choose our CD38 Recombinant for a seamless integration into your workflows, and experience the difference that quality and commitment can make. Whether you are developing new therapeutics or conducting essential research, we are here to support your journey and help you achieve your goals.

Making Smart Choices: Cd38 Recombinant Guarantees Peak Performance Your End-to-End Solution

Property	Details
Type	Recombinant Protein
Molecular Weight	40 kDa
Purity	>95% by SDS-PAGE
Concentration	1 mg/ml
Applications	ELISA, Western Blot, Functional Assays
Stability	Stable for 12 months at -20°C
Storage Buffer	PBS, pH 7.4

Comparative Performance of Recombinant Proteins in Various Applications

The chart above illustrates the comparative performance index of various applications utilizing recombinant proteins. The data highlights the significant differences in effectiveness across five distinct applications. Application D shows the highest performance index at 95, suggesting it may be the most suitable choice for high-performance requirements. Application B closely follows with an index of 90, indicating its robust capabilities in its own context. On the other hand, Application C, while performing well with an index of 85, may require some optimization to match the top contenders. Applications A and E score lower at 75 and 80 respectively, which may prompt further investigation into the efficiencies and potential enhancements available. Understanding these performance differentials can guide users in making informed decisions when selecting recombinant proteins for specific tasks, ensuring optimal results tailored to end-use applications.